We are a publicly traded NASDAQ INSM biopharmaceutical company dedicated to improving the lives of patients battling serious lung
Made For
We are a publicly traded NASDAQ INSM biopharmaceutical company dedicated to improving the lives of patients battling serious lung
Ashpool has identified 1 product used by Insmed
Ashpool has identified the primary mail recipient on this domain as Mimecast
Format | Success Rate |
first.last@insmed.com |
|
flast@insmed.com |
|
firstlast@insmed.com |
|